ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
ANALYSIS: The market saw some frantic trading in Air NZ stock after capital raise announcement.
ANALYSIS: The last one in New Zealand didn’t go so well for investors.
ANALYSIS: The probe into a conflict of interest left several stones unturned.
ANALYSIS: There’s more we can do – and should have done already.
ANALYSIS: Legislators and regulators have failed us, but lawyers have done worse.
ANALYSIS: Conflicts of interest mar the latest NZX market listing.
Kiwi Group Holdings would make an ideal NZX listing candidate.
Buy-now-pay-later stock Laybuy has gone from hot to not in short order.
ANALYSIS: The FMA’s latest legal action has some risk for Pushpay.
